Literature DB >> 25664207

Gabapentin and venlafaxine reduce pain in a patient with somatic symptom disorder.

Shady S Shebak1.   

Abstract

Entities:  

Year:  2014        PMID： 25664207      PMCID： PMC4318667          DOI： 10.4088/PCC.14l01632

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


× No keyword cloud information.
  6 in total

1.  Gabapentin leads to remission of somatoform pain disorder with major depression.

Authors:  I Maurer; H P Volz; H Sauer
Journal:  Pharmacopsychiatry       Date:  1999-11       Impact factor: 5.788

2.  The association of irritable bowel syndrome and somatization disorder.

Authors:  A R Miller; C S North; R E Clouse; R D Wetzel; E L Spitznagel; D H Alpers
Journal:  Ann Clin Psychiatry       Date:  2001-03       Impact factor: 1.567

3.  Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.

Authors:  S H Sindrup; F W Bach; C Madsen; L F Gram; T S Jensen
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

4.  Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome.

Authors:  K J Lee; J H Kim; S W Cho
Journal:  Aliment Pharmacol Ther       Date:  2005-11-15       Impact factor: 8.171

5.  Efficacy of venlafaxine for the long term treatment of chronic pain with associated major depressive disorder.

Authors:  Ronald H Bradley; Robert L Barkin; John Jerome; Kevin DeYoung; Charles William Dodge
Journal:  Am J Ther       Date:  2003 Sep-Oct       Impact factor: 2.688

6.  Alpha 2 Delta (α(2)δ) Ligands, Gabapentin and Pregabalin: What is the Evidence for Potential Use of These Ligands in Irritable Bowel Syndrome.

Authors:  Jeremy D Gale; Lesley A Houghton
Journal:  Front Pharmacol       Date:  2011-06-09       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.